Streetbeat News

Products Services

GILD

MRK

Gilead Sciences is withdrawing the US accelerated approval for Trodelvy as a bladder cancer treatment after a failed confirmatory trial. The decision, made with the FDA, does not affect other approved uses of Trodelvy. The TROPiCS-04 study did not meet its primary endpoint, impacting Gilead's stock slightly.

Portfolio Pulse from Vandana Singh

October 18, 2024 | 6:34 pm

CVRX

CVRx, Inc. announced that the AMA has accepted new CPT Category I codes for its Barostim therapy, which treats heart failure symptoms. This decision is expected to facilitate reimbursement and broaden patient access, with implementation set for January 1, 2026.

Portfolio Pulse from Benzinga Newsdesk

October 18, 2024 | 6:21 pm

ISPR

TLLTF

The cannabis vape industry is focusing on safety, innovation, and consumer engagement. Experts at the Benzinga Cannabis Capital Conference, including Steven Przybyia from Ispire Technology Inc. and Tim Conder from TILT Holdings Inc., discussed the importance of age-gating technology, self-regulation, and continuous innovation to ensure sustainable growth and differentiation in the market.

Portfolio Pulse from Jelena Martinovic

October 18, 2024 | 6:07 pm

AFRM

PYPL

The Consumer Financial Protection Bureau (CFPB) is introducing a rule to regulate Buy Now, Pay Later (BNPL) services similarly to credit cards. This move could impact companies like Affirm and PayPal, which offer BNPL services.

Portfolio Pulse from Benzinga Newsdesk

October 18, 2024 | 6:03 pm

CVS

DIA

GDX

NFLX

QQQ

SPY

Stocks rose on Friday, driven by strong earnings reports. Netflix hit record highs with a 10% surge, while gold miners rallied as gold prices reached new records. Oil prices fell below $70, and major indices like the Nasdaq 100 and S&P 500 saw gains. ETFs such as SPY, DIA, and QQQ also rose.

Portfolio Pulse from Piero Cingari

October 18, 2024 | 5:49 pm

BTCUSD

Crypto trader Cold Blooded Shiller predicts a bullish outlook for Bitcoin, highlighting technical analysis and market psychology as key factors for a potential breakout. Bitcoin's recent price action shows an uptrending structure, and surpassing $70,000 could lead to a rapid move towards $77,000-$80,000. The trader emphasizes the strong weekly RSI and the psychological market sentiment as indicators of a possible surge.

Portfolio Pulse from Khyathi Dalal

October 18, 2024 | 5:40 pm

NVS

The European Medicines Agency's panel has supported the approval of Novartis' Kisqali for early breast cancer treatment, based on positive trial results. The European Commission will make a final decision in two months.

Portfolio Pulse from Vandana Singh

October 18, 2024 | 5:37 pm

AAPL

GOOGL

META

MSFT

NVDA

QQQ

SPY

TSLA

The Market Clubhouse Morning Memo provides a trade strategy for SPY, QQQ, AAPL, MSFT, NVDA, GOOGL, META, and TSLA, highlighting key price levels and potential market movements. Traders are advised to monitor these stocks for breakouts or reversals, with a focus on managing risk and adjusting strategies based on market developments.

Portfolio Pulse from RIPS

October 18, 2024 | 5:31 pm

NVO

TSVT

Novo Nordisk's hemophilia drug Alhemo receives a positive opinion from the European Medicines Agency's CHMP, recommending its approval as a once-daily treatment for hemophilia A or B with inhibitors. The drug has shown significant efficacy in reducing bleeding episodes.

Portfolio Pulse from Vandana Singh

October 18, 2024 | 5:21 pm

COIN

PYPL

The EU's Markets in Crypto Assets (MiCA) regulation introduces a new era for the crypto industry, impacting stablecoin issuers and exchanges. Coinbase plans to delist non-compliant stablecoins, while PayPal and Circle have taken steps to align with MiCA. The regulation aims to enhance consumer protection and integrate crypto into traditional finance.

Portfolio Pulse from European Capital Insights

October 18, 2024 | 5:13 pm